CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021		24,592,098
Beginning balance at Dec. 31, 2021	$ 1,713,990	$ 246	$ 1,529,969	$ 174,572	$ 9,203
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	$ 21,792		21,763	29
Exercise of stock options (in shares)	377	377
Exercise of stock options	$ 14		14
Issuance of restricted stock, net (in shares)		422,520
Issuance of restricted stock, net	(2,913)	$ 4	(2,917)
Repurchase of common stock (in shares)		(612,104)
Repurchase of common stock	(40,116)	$ (6)	(37,905)	(2,205)
Common stock dividends	(59,376)			(59,376)
Foreign currency translation adjustment	(43,425)				(43,425)
Unrealized (losses) gains on marketable securities, net of tax	(846)				(846)
Net income	46,670			46,670
Ending balance (in shares) at Dec. 31, 2022		24,402,891
Ending balance at Dec. 31, 2022	1,635,790	$ 244	1,510,924	159,690	(35,068)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	$ 19,772		19,557	215
Exercise of stock options (in shares)	4,138	4,138
Exercise of stock options	$ 223		223
Issuance of restricted stock, net (in shares)		128,860
Issuance of restricted stock, net	(5,047)	$ 1	(5,048)
Repurchase of common stock (in shares)		(129,073)
Repurchase of common stock	(10,013)	$ (1)	(8,006)	(2,006)
Common stock dividends	(58,819)			(58,819)
Foreign currency translation adjustment	533				533
Unrealized (losses) gains on marketable securities, net of tax	288				288
Net income	$ 69,791			69,791
Ending balance (in shares) at Dec. 31, 2023	24,406,816	24,406,816
Ending balance at Dec. 31, 2023	$ 1,652,518	$ 244	1,517,650	168,871	(34,247)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	$ 25,571		25,571
Exercise of stock options (in shares)	8,056	8,056
Exercise of stock options	$ 512		512
Issuance of restricted stock, net (in shares)		207,439
Issuance of restricted stock, net	(3,831)	$ 2	(3,833)
Repurchase of common stock (in shares)		(119,926)
Repurchase of common stock	(11,538)	$ (1)	(7,486)	(4,051)
Common stock dividends	(59,099)			(59,099)
Foreign currency translation adjustment	(54,564)				(54,564)
Unrealized (losses) gains on marketable securities, net of tax	246				246
Net income	$ 112,684			112,684
Ending balance (in shares) at Dec. 31, 2024	24,502,385	24,502,385
Ending balance at Dec. 31, 2024	$ 1,662,499	$ 245	$ 1,532,414	$ 218,405	$ (88,565)